The prediction of the chance to conceive in subfertile couples von Eimers, J. Mariëtta, te Velde, Egbert R., Gerritse, Rene, Vogelzang, Elly T., Looman, Caspar W.N., Habbema, J. Dik F.

Volltext

Physical complaints and emotional stress related to routine diagnostic procedures of the fertility investigation von Eimers, J. M., Omtzigt, A. M., Vogelzang, E. T., Van Ommen, R., Habbema, J. D. E., Te Velde, E. R.

Volltext

Patient-reported quality-of-life analysis of radium-223 dichloride from the phase III ALSYMPCA study von Nilsson, S., Cislo, P., Sartor, O., Vogelzang, N.J., Coleman, R.E., O'Sullivan, J.M., Reuning-Scherer, J., Shan, M., Zhan, L., Parker, C.

Volltext

Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer von Parker, C, Nilsson, S, Heinrich, D, Helle, S.I, O'Sullivan, J.M, Fosså, S.D, Chodacki, A, Wiechno, P, Logue, J, Seke, M, Widmark, A, Johannessen, D.C, Hoskin, P, Bottomley, D, James, N.D, Solberg, A, Syndikus, I, Kliment, J, Wedel, S, Boehmer, S, Dall'Oglio, M, Franzén, L, Coleman, R, Vogelzang, N.J, O'Bryan-Tear, C.G, Staudacher, K, Garcia-Vargas, J, Shan, M, Bruland, Ø.S, Sartor, O

Volltext

European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults von van Prehn, Joffrey, Reigadas, Elena, Vogelzang, Erik H., Bouza, Emilio, Hristea, Adriana, Guery, Benoit, Krutova, Marcela, Norén, Torbjorn, Allerberger, Franz, Coia, John E., Goorhuis, Abraham, van Rossen, Tessel M., Ooijevaar, Rogier E., Burns, Karen, Scharvik Olesen, Bente R., Tschudin-Sutter, Sarah, Wilcox, Mark H., Vehreschild, Maria J.G.T., Fitzpatrick, Fidelma, Kuijper, Ed J.

Volltext

Docetaxel and prednisone with or without lenalidomide in chemotherapy-naive patients with metastatic castration-resistant prostate cancer (MAINSAIL): a randomised, double-blind, pl... von Petrylak, Daniel P, Prof, Vogelzang, Nicholas J, MD, Budnik, Nikolay, MD, Wiechno, Pawel Jan, MD, Sternberg, Cora N, Prof, Doner, Kevin, MD, Bellmunt, Joaquim, MD, Burke, John M, MD, de Olza, Maria Ochoa, MD, Choudhury, Ananya, PhD, Gschwend, Juergen E, Prof, Kopyltsov, Evgeny, MD, Flechon, Aude, MD, Van As, Nicolas, MD, Houede, Nadine, MD, Barton, Debora, MD, Fandi, Abderrahim, MD, Jungnelius, Ulf, MD, Li, Shaoyi, PhD, de Wit, Ronald, Prof, Fizazi, Karim, Prof

Volltext

An exploratory analysis of alkaline phosphatase, lactate dehydrogenase, and prostate-specific antigen dynamics in the phase 3 ALSYMPCA trial with radium-223 von Sartor, O., Coleman, R.E., Nilsson, S., Heinrich, D., Helle, S.I., O’Sullivan, J.M., Vogelzang, N.J., Bruland, Ø., Kobina, S., Wilhelm, S., Xu, L., Shan, M., Kattan, M.W., Parker, C.

Volltext

Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer: Long-Term Survival Analysis of the Randomized Phase III E3805 CHAARTED Trial von Kyriakopoulos, Christos E, Chen, Yu-Hui, Carducci, Michael A, Liu, Glenn, Jarrard, David F, Hahn, Noah M, Shevrin, Daniel H, Dreicer, Robert, Hussain, Maha, Eisenberger, Mario, Kohli, Manish, Plimack, Elizabeth R, Vogelzang, Nicholas J, Picus, Joel, Cooney, Matthew M, Garcia, Jorge A, DiPaola, Robert S, Sweeney, Christopher J

Volltext

Non-BRCA DNA Damage Repair Gene Alterations and Response to the PARP Inhibitor Rucaparib in Metastatic Castration-Resistant Prostate Cancer: Analysis From the Phase II TRITON2 Stud... von Abida, Wassim, Campbell, David, Patnaik, Akash, Shapiro, Jeremy D, Sautois, Brieuc, Vogelzang, Nicholas J, Voog, Eric G, Bryce, Alan H, McDermott, Ray, Ricci, Francesco, Rowe, Julie, Zhang, Jingsong, Piulats, Josep Maria, Fizazi, Karim, Merseburger, Axel S, Higano, Celestia S, Krieger, Laurence E, Ryan, Charles J, Feng, Felix Y, Simmons, Andrew D, Loehr, Andrea, Despain, Darrin, Dowson, Melanie, Green, Foad, Watkins, Simon P, Golsorkhi, Tony, Chowdhury, Simon

Volltext

Lenvatinib plus pembrolizumab in patients with either treatment-naive or previously treated metastatic renal cell carcinoma (Study 111/KEYNOTE-146): a phase 1b/2 study von Lee, Chung-Han, Shah, Amishi Yogesh, Rasco, Drew, Rao, Arpit, Taylor, Matthew H, Di Simone, Christopher, Hsieh, James J, Pinto, Alvaro, Shaffer, David R, Girones Sarrio, Regina, Cohn, Allen Lee, Vogelzang, Nicholas J, Bilen, Mehmet Asim, Gunnestad Ribe, Sara, Goksel, Musaberk, Tennøe, Øyvind Krohn, Richards, Donald, Sweis, Randy F, Courtright, Jay, Heinrich, Daniel, Jain, Sharad, Wu, Jane, Schmidt, Emmett V, Perini, Rodolfo F, Kubiak, Peter, Okpara, Chinyere E, Smith, Alan D, Motzer, Robert J

Volltext

Lenvatinib plus pembrolizumab in patients with advanced endometrial cancer: an interim analysis of a multicentre, open-label, single-arm, phase 2 trial von Makker, Vicky, Rasco, Drew, Vogelzang, Nicholas J, Brose, Marcia S, Cohn, Allen L, Mier, James, Di Simone, Christopher, Hyman, David M, Stepan, Daniel E, Dutcus, Corina E, Schmidt, Emmett V, Guo, Matthew, Sachdev, Pallavi, Shumaker, Robert, Aghajanian, Carol, Taylor, Matthew

Volltext

Axitinib versus sorafenib as first-line therapy in patients with metastatic renal-cell carcinoma: a randomised open-label phase 3 trial von Hutson, Thomas E, Prof, Lesovoy, Vladimir, Prof, Al-Shukri, Salman, Prof, Stus, Viktor P, Prof, Lipatov, Oleg N, Prof, Bair, Angel H, PhD, Rosbrook, Brad, MS, Chen, Connie, PharmD, Kim, Sinil, MD, Vogelzang, Nicholas J, Prof

Volltext

Efficacy and safety of rucaparib in previously treated, locally advanced or metastatic urothelial carcinoma from a phase 2, open-label trial (ATLAS) von Grivas, P, Loriot, Y, Morales-Barrera, R, Teo, M Y, Zakharia, Y, Feyerabend, S, Vogelzang, N J, Grande, E, Adra, N, Alva, A, Necchi, A, Rodriguez-Vida, A, Gupta, S, Josephs, D H, Srinivas, S, Wride, K, Thomas, D, Simmons, A, Loehr, A, Dusek, R L, Nepert, D, Chowdhury, S

Volltext

Efficacy and safety of pembrolizumab in metastatic urothelial carcinoma: results from KEYNOTE-045 and KEYNOTE-052 after up to 5 years of follow-up von Balar, A.V., Castellano, D.E., Grivas, P., Vaughn, D.J., Powles, T., Vuky, J., Fradet, Y., Lee, J.-L., Fong, L., Vogelzang, N.J., Climent, M.A., Necchi, A., Petrylak, D.P., Plimack, E.R., Xu, J.Z., Imai, K., Moreno, B.H., Bellmunt, J., de Wit, R., O’Donnell, P.H.

Volltext

Plasminogen controls inflammation and pathogenesis of influenza virus infections via fibrinolysis von Berri, Fatma, Rimmelzwaan, Guus F, Hanss, Michel, Albina, Emmanuel, Foucault-Grunenwald, Marie-Laure, Lê, Vuong B, Vogelzang-van Trierum, Stella E, Gil, Patrica, Camerer, Eric, Martinez, Dominique, Lina, Bruno, Lijnen, Roger, Carmeliet, Peter, Riteau, Béatrice

Volltext

Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled... von Fizazi, Karim, Prof Dr, Scher, Howard I, Prof, Molina, Arturo, MD, Logothetis, Christopher J, Prof, Chi, Kim N, MD, Jones, Robert J, PhD, Staffurth, John N, MD, North, Scott, MD, Vogelzang, Nicholas J, MD, Saad, Fred, Prof, Mainwaring, Paul, MD, Harland, Stephen, MD, Goodman, Oscar B, MD, Sternberg, Cora N, MD, Li, Jin Hui, PhD, Kheoh, Thian, PhD, Haqq, Christopher M, MD, de Bono, Johann S, Prof

Volltext

Atezolizumab versus chemotherapy in patients with platinum-treated locally advanced or metastatic urothelial carcinoma (IMvigor211): a multicentre, open-label, phase 3 randomised c... von Powles, Thomas, Durán, Ignacio, van der Heijden, Michiel S, Loriot, Yohann, Vogelzang, Nicholas J, De Giorgi, Ugo, Oudard, Stéphane, Retz, Margitta M, Castellano, Daniel, Bamias, Aristotelis, Fléchon, Aude, Gravis, Gwenaëlle, Hussain, Syed, Takano, Toshimi, Leng, Ning, Kadel, Edward E, Banchereau, Romain, Hegde, Priti S, Mariathasan, Sanjeev, Cui, Na, Shen, Xiaodong, Derleth, Christina L, Green, Marjorie C, Ravaud, Alain

Volltext

Rucaparib in Men With Metastatic Castration-Resistant Prostate Cancer Harboring a BRCA1 or BRCA2 Gene Alteration von Abida, Wassim, Patnaik, Akash, Campbell, David, Shapiro, Jeremy, Bryce, Alan H, McDermott, Ray, Sautois, Brieuc, Vogelzang, Nicholas J, Bambury, Richard M, Voog, Eric, Zhang, Jingsong, Piulats, Josep M, Ryan, Charles J, Merseburger, Axel S, Daugaard, Gedske, Heidenreich, Axel, Fizazi, Karim, Higano, Celestia S, Krieger, Laurence E, Sternberg, Cora N, Watkins, Simon P, Despain, Darrin, Simmons, Andrew D, Loehr, Andrea, Dowson, Melanie, Golsorkhi, Tony, Chowdhury, Simon

Volltext

Chemotherapy following radium-223 dichloride treatment in ALSYMPCA von Sartor, Oliver, Hoskin, Peter, Coleman, Robert E., Nilsson, Sten, Vogelzang, Nicholas J., Petrenciuc, Oana, Staudacher, Karin, Thuresson, Marcus, Parker, Christopher

Volltext

Cabozantinib in hepatocellular carcinoma: results of a phase 2 placebo-controlled randomized discontinuation study von Kelley, R.K., Verslype, C., Cohn, A.L., Yang, T.-S., Su, W.-C., Burris, H., Braiteh, F., Vogelzang, N., Spira, A., Foster, P., Lee, Y., Van Cutsem, E.

Volltext